What is the ICD-10-CM code for alprazolam (Xanax) abuse?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10-CM Code for Alprazolam (Xanax) Abuse

The ICD-10-CM code for alprazolam abuse is F13.10 (Sedative, hypnotic, or anxiolytic use disorder, mild) or F13.1 (Sedative, hypnotic, or anxiolytic abuse).

Understanding the Coding Structure

  • Alprazolam is classified as a benzodiazepine, which falls under the sedative, hypnotic, or anxiolytic drug category in ICD-10-CM coding 1
  • The F13 category encompasses all sedative, hypnotic, or anxiolytic-related disorders, including benzodiazepines like alprazolam 2
  • The fourth character distinguishes between abuse (.1) and dependence (.2), with abuse representing a less severe pattern of problematic use 3

Specific Code Selection Algorithm

Use F13.10 when the patient meets criteria for mild sedative use disorder or abuse pattern without physiological dependence features 3

Use F13.20 (Sedative, hypnotic, or anxiolytic dependence, uncomplicated) when the patient demonstrates:

  • Tolerance requiring dose escalation beyond prescribed amounts 2, 3
  • Withdrawal symptoms upon discontinuation 2, 3
  • Loss of control over use despite attempts to cut down 4
  • Continued use despite knowledge of physical or psychological harm 5

Use F13.23 when active intoxication is present at the time of encounter 5

Clinical Context for Accurate Coding

  • Alprazolam has particularly high misuse liability compared to other benzodiazepines due to its rapid absorption, quick brain penetration, and reinforcing properties 2, 3
  • The median therapeutic concentration is 0.08 mg/L, but concentrations ≥0.1 mg/L are associated with increased toxicity risk, particularly when combined with other substances 5
  • In 94.9% of alprazolam-related deaths, other drugs were present, most commonly opioids (64.6%), other benzodiazepines (44.4%), and alcohol (34.5%), indicating polysubstance use patterns 5

Common Coding Pitfalls to Avoid

  • Do not code as F13.9 (unspecified) when sufficient clinical information exists to determine abuse versus dependence—this represents inadequate documentation 3
  • Distinguish between prescribed long-term use for legitimate anxiety/panic disorder (which may show physiological dependence but not abuse) versus misuse patterns characterized by dose escalation, doctor shopping, or non-medical use 4
  • Patients using alprazolam "as required" rather than as prescribed, even at therapeutic doses, may represent controlled self-medication of underlying psychopathology rather than abuse, requiring careful clinical judgment 4
  • Add fifth character to specify current clinical status: .10 (mild), .20 (moderate/severe uncomplicated), .21 (in remission), .23 (with intoxication) 5, 3

References

Research

Alprazolam and diazepam: addiction potential.

Journal of substance abuse treatment, 1991

Research

A Review of Alprazolam Use, Misuse, and Withdrawal.

Journal of addiction medicine, 2018

Research

Long-term alprazolam use: abuse, dependence or treatment?

Psychopharmacology bulletin, 1991

Related Questions

Which of the following medications, Alprazolam (benzodiazepine), Bupropion (antidepressant), or Amitriptyline (tricyclic antidepressant), has the highest risk of dependence?
What is the appropriate action for an Adult-Gerontology Acute Care Nurse Practitioner (AGACNP) regarding a postoperative patient's request to resume alprazolam (Xanax) 0.5 mg orally (PO) every night at bedtime and sertraline (Zoloft) 100 mg PO daily for generalized anxiety disorder after a total hip replacement?
What are the contraindications for Alprazolam (Xanax)?
What are the guidelines for prescribing Alprazolam (Xanax) for anxiety disorders?
What drug group does Alprazolam (benzodiazepine) belong to?
In an adult with normal renal function who had a TIA and a first seizure after receiving an IV loading dose of levetiracetam (Keppra), what oral levetiracetam dose should be used for conversion?
Is high‑energy synchronized cardioversion harmful as the initial shock in a hemodynamically stable patient with sustained monomorphic ventricular tachycardia after a full amiodarone loading dose?
In an elderly patient with newly discovered splenomegaly (~20 cm) of unknown cause, how should Epstein‑Barr virus infection be evaluated and managed?
Does spironolactone affect electrolytes?
What is the appropriate workup and initial management for a patient presenting with arthritis?
Can a patient with systemic lupus erythematosus (SLE) safely take turmeric (curcumin) and oil of oregano supplements while on methotrexate (MTX)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.